Vijgen, Johan https://orcid.org/0000-0003-4928-4836
Račkauskas, Gediminas
Dilling-Boer, Dagmara
Sarkozy, Andrea
Ciconte, Giuseppe
Vicedomini, Gabriele Giuseppe
Pappone, Carlo
Funding for this research was provided by:
Biosense Webster, Inc.
Article History
Received: 17 March 2023
Accepted: 14 May 2023
First Online: 25 May 2023
Declarations
:
: The study met the regulatory requirements of the applicable European medical device regulation and the local government. Ethics committee approvals were received June 28, 2021. The study was conducted in compliance with Good Clinical Practice, European standard EN ISO 14155, and the Declaration of Helsinki.
: All enrolled participants provided written informed consent prior to undergoing study procedures.
: Drs. Johan Vijgen, Gediminas Račkauskas, and Dagmara Dilling-Boer declare no conflicts of interest. Dr. Andrea Sarkozy reports personal fees from Biosense Webster, Inc., outside of the submitted work. Drs. Giuseppe Ciconte, Gabriele Giuseppe Vicedomini, and Carlo Pappone report participation on an advisory board and consulting fees from Biosense Webster, Inc., related to the submitted work.